Lidocaine on Pain Relief and IL and Substance P in Fibromyalgia

Summary

The study's primary objective is to evaluate the effect of intravenous lidocaine on pain and plasma interleukin-1 (IL-1), interleukin-6 (IL-6) and substance P in patients with fibromyalgia. As secondary objectives: evaluate the clinical manifestations, and plasma concentration of lidocaine.

Timeline

Start

2010-01

Primary completion

2012-07

Completion

2012-12

Drugs

Indications